Holding(s) in Company

Cambridge Antibody Tech Group PLC 09 September 2004 SCHEDULE 10 NOTIFICATION OF MAJOR INTERESTS IN SHARES 1) Name of company Cambridge Antibody Technology 2) Name of shareholder having a major interest The Goldman Sachs Group Inc 3) Please state whether notification indicates that it is in respect of holding of the shareholder named in 2 above or in respect of a non-beneficial interest or in the case of an individual holder if it is a holding of that person's spouse or children under the age of 18 Goldman Sachs Securities (Nominees) Limited non-beneficial The Depositary Trust Company, New York non-beneficial Goldman Sachs Securities (Nominees) Limited beneficial Goldman Sachs International (CREST a/c CREPTEMP) beneficial Goldman Sachs JBWere Managed Funds Limited beneficial 4) Name of the registered holder(s) and, if more than one holder, the number of shares held by each of them Goldman Sachs Securities (Nominees) Limited 876,025 The Depositary Trust Company, New York 55,700 Goldman Sachs Securities (Nominees) Limited 1,400 Goldman Sachs International (CREST a/c CREPTEMP) 190,674 Goldman Sachs JBWere Managed Funds Limited 122,700 5) Number of shares/amount of stock acquired not disclosed 6) Percentage of issued class 3.03% 7) Number of shares/amount of stock disposed None 8) Percentage of issued class N/A 9) Class of security Ordinary 10 pence shares 10) Date of transaction Not known 11) Date company informed 9 September 2004 12) Total holding following this notification 1,246,499 13) Total percentage holding of issued class following this notification 3.03% 14) Any additional information None 15) Name of contact and telephone number for queries Justin Hoskins 01223 898589 16) Name and signature of authorised company official responsible for making this notification Diane Mellett, Company Secretary Date of notification 9 September 2004 This information is provided by RNS The company news service from the London Stock Exchange
UK 100

Latest directors dealings